Investigation Overview
An investigation on behalf of investors of Innate Pharma S.A. (NASDAQ: IPHA) shares over potential securities laws violations by Innate Pharma S.A. and certain of its directors and officers in connection with certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Innate Pharma S.A. (NASDAQ: I...
You must register (for free) or login to view the entire investigation.